C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/70 (2006.01) C12Q 1/68 (2006.01) G01N 33/569 (2006.01)
Patent
CA 2703165
The invention provides compositions and methods useful for early detection of congenital CMV infection, predicting the likelihood and severity of congenital CMV disease, and monitoring the efficacy of therapeutic approaches. Compositions of the present invention include biomarkers that are differentially expressed in CMV- infected mothers and fetuses compared to uninfected individuals.
L'invention propose des compositions et des procédés utiles pour une détection précoce d'infections à CMV congénital, prévoyant la probabilité et l'importance d'un CMV congénital et surveillant l'efficacité des approches thérapeutiques. Des compositions de l'invention comprennent des biomarqueurs qui sont exprimés différemment chez des mères et des ftus affectés par le CMV, par comparaison à des individus non affectés.
Maidji Ekaterina
Mcdonagh Susan Jane
Pereira Lenore
Tabata Takako
Fetherstonhaugh & Co.
The Regents Of The University Of California
LandOfFree
Biomarkers for prenatal diagnosis of congenital cytomegalovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers for prenatal diagnosis of congenital cytomegalovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for prenatal diagnosis of congenital cytomegalovirus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1573417